Daratumumab (JNJ-54767414)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Daratumumab (JNJ-54767414), covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy Participants [Phase 1]